Seroprevalence of Epstein-Barr Virus Antibodies and Complement C3/C4 Levels in Immunocompromised (Malignant Tumors and Organ Transplant Recipients) Patients

Authors

DOI:

https://doi.org/10.69923/hqk7rr18

Keywords:

EBV IgG, EBV IgM, Complement C3/C4, Tumors ,Organ Transplant

Abstract

This cross-sectional study (4 Oct 2024–5Mar 2025) assessed Epstein-Barr virus (EBV) seroprevalence and complement activity in 100 immunocompromised patients (80 cancers and 20 kidney transplant) versus 50 healthy blood donors at Baqubah Teaching Hospital. Serum IgG/IgM antibodies were quantified by ELISA, alongside hematologic indices and complement components C3 and C4. EBV exposure was substantially higher in the patient group: 17% were IgG-positive and 4% IgM-positive, compared with only 3% IgG-positivity and 0% IgM-positivity in controls, underscoring greater past and recent infection in immunocompromised hosts. Hematologic profiles reflected this vulnerability. Patients exhibited significantly lower haemoglobin (11.57 ± 0.19 g/dL vs. 12.75 ± 0.16 g/dL; p = 0.001) and lymphocyte counts (1.54 ± 0.07 × 10³ µL⁻¹ vs. 1.89 ± 0.13 × 10³ µL⁻¹; p = 0.02), alongside markedly depressed total white blood cell counts (4.90 ± 0.18 × 10³ µL⁻¹ vs. 9.90 ± 0.29 × 10³ µL⁻¹; p = 0.001). Red blood cell counts were paradoxically higher in patients (4.11 ± 0.10 × 10⁶ µL⁻¹ vs. 3.65 ± 0.10 × 10⁶ µL⁻¹; p = 0.001), while platelet numbers did not differ. Complement analysis revealed a pronounced rise in C3 among patients (116.68 ± 2.17 mg/dL) relative to controls (91.26 ± 3.63 mg/dL; p = 0.001), suggesting enhanced innate immune activation; C4 levels remained comparable (31.46 ± 0.89 mg/dL vs. 31.27 ± 1.11 mg/dL; p = 0.801). In conclusion, the data highlight a significantly greater EBV burden in tumour and transplant recipients, accompanied by characteristic shifts in blood counts and elevated C3.

Downloads

Download data is not yet available.

Author Biographies

  • Aya Wesmii Ibrahim, Department of Biology, College of Science, Diyala University, Diyala, Iraq

    Aya Wesmii Ibrahim is Lecturer at Bilad Al Rafidain University, Iraq. She holds a Bachelor's degree in Biology Sciences from the College of Science, University of Diyala, Iraq. To contact her, please email:

  • Ibtihal Hameed Mohsin, University of Diyala

    Ibtihal Hameed Mohsin is Associate Professor at College of  Science, University of Diyala, Iraq. He received the B.Sc. degree in biology science from the University of  Diyala/ science college and M.Sc. degree from College of Education for Pure Science, University of Diyala, Iraq.. He Holds a PhD degree in biology Science /micrology with specialization in virology/ immunology. His research areas are virology and immunology  She has published several scientific papers in national, international conferences and journals. He can be contacted at email: ibtihalhameed@ uodiyala.edu.iq

Downloads

Published

09/30/2025

How to Cite

[1]
A. Wesmii Ibrahim and I. H. . Mohsin, “Seroprevalence of Epstein-Barr Virus Antibodies and Complement C3/C4 Levels in Immunocompromised (Malignant Tumors and Organ Transplant Recipients) Patients”, IJApSc, vol. 2, no. 3, pp. 24–34, Sep. 2025, doi: 10.69923/hqk7rr18.

Most read articles by the same author(s)

1 2 3 4 5 6 > >>